Wang X, Iyaswamy A, Xu D, Krishnamoorthi S, Sreenivasmurthy SG, Yang Y, Li Y, Chen C, Li M, Li HW and Wong MS: Real-time detection and visualization of amyloid-β aggregates induced by hydrogen peroxide in cell and mouse models of Alzheimer's disease. ACS Appl Mater Interfaces. 15:39–47. 2023. View Article : Google Scholar

Shih YH, Tu LH, Chang TY, Ganesan K, Chang WW, Chang PS, Fang YS, Lin YT, Jin LW and Chen YR: TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer's disease. Nat Commun. 11:59502020. View Article : Google Scholar

Nasaruddin ML, Pan X, McGuinness B, Passmore P, Kehoe PG, Holscher C, Graham SF and Green BD: Evidence that parietal lobe fatty acids may be more profoundly affected in moderate Alzheimer's disease (AD) pathology than in severe AD pathology. Metabolites. 8:692018. View Article : Google Scholar : PubMed/NCBI

Chen YG: Research progress in the pathogenesis of Alzheimer's disease. Chin Med J (Engl). 131:1618–1624. 2018. View Article : Google Scholar : PubMed/NCBI

Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzériat K, Dansokho C, Dierkes T, Gelders G, Heneka MT, et al: Targeting neuroinflammation to treat Alzheimer's disease. CNS Drugs. 31:1057–1082. 2017. View Article : Google Scholar : PubMed/NCBI

Finneran DJ and Nash KR: Neuroinflammation and fractalkine signaling in Alzheimer's disease. J Neuroinflammation. 16:302019. View Article : Google Scholar : PubMed/NCBI

Souza LC, Filho CB, Goes AT, Fabbro LD, de Gomes MG, Savegnago L, Oliveira MS and Jesse CR: Neuroprotective effect of physical exercise in a mouse model of Alzheimer's disease induced by β-amyloid 2013. 1-40 peptide. Neurotox Res. 24:148–163. 2013. View Article : Google Scholar : PubMed/NCBI

Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ and Bowers WJ: Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation. 2:232005. View Article : Google Scholar : PubMed/NCBI

Ma K, Mount HTJ and McLaurin J: Region-specific distribution of β-amyloid peptide and cytokine expression in TgCRND8 mice. Neurosci Lett. 492:5–10. 2011. View Article : Google Scholar : PubMed/NCBI

Wu YY, Hsu JL, Wang HC, Wu SJ, Hong CJ and Cheng IHJ: Alterations of the neuroinflammatory markers IL-6 and TRAIL in Alzheimer's disease. Dement Geriatr Cogn Dis Extra. 5:424–434. 2015. View Article : Google Scholar : PubMed/NCBI

Takeda S, Sato N, Ikimura K, Nishino H, Rakugi H and Morishita R: Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol Aging. 34:2064–2070. 2013. View Article : Google Scholar : PubMed/NCBI

Mann DM, Tucker CM and Yates PO: Alzheimer's disease: An olfactory connection? Mech Ageing Dev. 42:1–15. 1988. View Article : Google Scholar : PubMed/NCBI

Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K and Miklossy J: Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci. 30:20–25. 2003. View Article : Google Scholar : PubMed/NCBI

Abe Y, Ikegawa N, Yoshida K, Muramatsu K, Hattori S, Kawai K, Murakami M, Tanaka T, Goda W, Goto M, et al: Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model. Acta Neuropathol Commun. 8:672020. View Article : Google Scholar : PubMed/NCBI

Walker DG, Dalsing-Hernandez JE, Campbell NA and Lue LF: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation. Exp Neurol. 215:5–19. 2009. View Article : Google Scholar :

Ham HJ, Lee YS, Yun J, Son DJ, Lee HP, Han SB and Hong JT: K284-6111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of chitinase-3-like 1 regulating ERK-dependent PTX3 pathway. J Neuroinflammation. 17:3502020. View Article : Google Scholar : PubMed/NCBI

Cullen NC, Malarstig AN, Stomrud E, Hansson O and Mattsson-Carlgren N: Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition. Sci Rep. 11:19652021. View Article : Google Scholar : PubMed/NCBI

Voet S, Mc Guire C, Hagemeyer N, Martens A, Schroeder A, Wieghofer P, Daems C, Staszewski O, Vande Walle L, Jordao MJC, et al: A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation. Nat Commun. 9:20362018. View Article : Google Scholar : PubMed/NCBI

Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, et al: Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 18:965–977. 2015. View Article : Google Scholar : PubMed/NCBI

Sierra A, Beccari S, Diaz-Aparicio I, Encinas JM, Comeau S and Tremblay MÈ: Surveillance, phagocytosis, and inflammation: How never-resting microglia influence adult hippocampal neurogenesis. Neural Plast. 2014:6103432014. View Article : Google Scholar : PubMed/NCBI

Ben-Yehuda H, Matcovitch-Natan O, Kertser A, Spinrad A, Prinz M, Amit I and Schwartz M: Maternal Type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress. Mol Psychiatr. 25:1050–1067. 2020. View Article : Google Scholar

Town T, Nikolic V and Tan J: The microglial 'activation' continuum: From innate to adaptive responses. J Neuroinflammation. 2:242005. View Article : Google Scholar

Leng F and Edison P: Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nat Rev Neurol. 17:157–172. 2021. View Article : Google Scholar

Song WM, Joshita S, Zhou Y, Ulland TK, Gilfillan S and Colonna M: Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J Exp Med. 215:745–760. 2018. View Article : Google Scholar : PubMed/NCBI

Tansey MG, McCoy MK and Frank-Cannon TC: Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol. 208:1–25. 2007. View Article : Google Scholar : PubMed/NCBI

Jankowsky JL and Patterson PH: Cytokine and growth factor involvement in long-term potentiation. Mol Cell Neurosci. 14:273–286. 1999. View Article : Google Scholar : PubMed/NCBI

Das S and Basu A: Inflammation: A new candidate in modulating adult neurogenesis. J Neurosci Res. 86:1199–1208. 2008. View Article : Google Scholar

Heneka MT, Carson MJ, El KJ, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al: Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14:388–405. 2015. View Article : Google Scholar : PubMed/NCBI

Giridharan S and Srinivasan M: Mechanisms of NF-κB p65 and strategies for therapeutic manipulation. J Inflamm Res. 11:407–419. 2018. View Article : Google Scholar :

Noort AR, Tak PP and Tas SW: Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res Ther. 17:152015. View Article : Google Scholar

Mattson MP and Meffert MK: Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13:852–860. 2006. View Article : Google Scholar : PubMed/NCBI

Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, Ueda S, Okajima H, Terajima H and Uemoto S: Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury. Proc Natl Acad Sci USA. 116:13533–13542. 2019. View Article : Google Scholar

Liu Y, Li D, Jiang Q, Zhang Q, Liu P, Wang L, Zong M, Zhang Q, Li H, An Y, et al: (3R, 7R)-7-Acetoxyl-9-Oxo-de-O-methyllasiodiplodin, a secondary metabolite of penicillium Sp., inhibits LPS-mediated inflammation in RAW 264.7 macrophages through blocking ERK/MAPKs and NF-κB signaling pathways. Inflammation. 42:1463–1473. 2019. View Article : Google Scholar : PubMed/NCBI

Christian F, Smith EL and Carmody RJ: The regulation of NF-κB subunits by phosphorylation. Cells. 5:122016. View Article : Google Scholar

Oeckinghaus A and Ghosh S: The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 1:a0000342009. View Article : Google Scholar

Yano H, Sakai M, Matsukawa T, Yagi T, Naganuma T, Mitsushima M, Iida S, Inaba Y, Inoue H, Unoki-Kubota H, et al: PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes. Sci Rep. 8:142902018. View Article : Google Scholar : PubMed/NCBI

Terai K, Matsuo A and McGeer PL: Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res. 735:159–168. 1996. View Article : Google Scholar : PubMed/NCBI

Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, et al: Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain. 131:651–664. 2008. View Article : Google Scholar : PubMed/NCBI

Kolesnick R and Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:325–328. 1994. View Article : Google Scholar : PubMed/NCBI

Kitamura Y, Shimohama S, Ota T, Matsuoka Y, Nomura Y and Taniguchi T: Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains. Neurosci Lett. 237:17–20. 1997. View Article : Google Scholar : PubMed/NCBI

Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, Tone Y, Tong Y and Song W: Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int J Neuropsychopharmacol. 15:77–90. 2012. View Article : Google Scholar

Snow WM and Albensi BC: Neuronal gene targets of NF-κB and their dysregulation in Alzheimer's disease. Front Mol Neurosci. 9:1182016. View Article : Google Scholar

Wang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, Chin M, Li Y, Le D, Zhou Y, et al: Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy. Nat Commun. 13:19692022. View Article : Google Scholar

López N, Tormo C, De Blas I, Llinares I and Alom J: Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. J Alzheimers Dis. 33:823–829. 2013. View Article : Google Scholar

Wang SW, Yang SG, Liu W, Zhang YX, Xu PX, Wang T, Ling TJ and Liu RT: Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer's disease. Behav Brain Res. 296:109–117. 2016. View Article : Google Scholar

Sun HJ, Xue DD, Lu BZ, Li Y, Sheng LX, Zhu Z, Zhou YW, Zhang JX, Lin GJ, Lin SZ, et al: A novel synthetic steroid of 2β,3α,5α-trihydroxy-androst-6-one alleviates the loss of rat retinal ganglion cells caused by acute intraocular hypertension via inhibiting the inflammatory activation of microglia. Molecules. 24:2522019. View Article : Google Scholar

Belkhelfa M, Rafa H, Medjeber O, Arroul-Lammali A, Behairi N, Abada-Bendib M, Makrelouf M, Belarbi S, Masmoudi AN, Tazir M and Touil-Boukoffa C: IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. J Interferon Cytokine Res. 34:839–847. 2014. View Article : Google Scholar : PubMed/NCBI

Sui Y, Stehno-Bittel L, Li S, Loganathan R, Dhillon NK, Pinson D, Nath A, Kolson D, Narayan O and Buch S: CXCL10-induced cell death in neurons: Role of calcium dysregulation. Eur J Neurosci. 23:957–964. 2006. View Article : Google Scholar : PubMed/NCBI

Xu PX, Wang SW, Yu XL, Su YJ, Wang T, Zhou WW, Zhang H, Wang YJ and Liu RT: Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation. Behav Brain Res. 264:173–180. 2014. View Article : Google Scholar : PubMed/NCBI

Budzynska B, Faggio C, Kruk-Slomka M, Samec D, Nabavi SF, Sureda A, Devi KP and Nabavi SM: Rutin as neuroprotective agent: From bench to bedside. Curr Med Chem. 26:5152–5164. 2019. View Article : Google Scholar

Sun XY, Li LJ, Dong QX, Zhu J, Huang YR, Hou SJ, Yu XL and Liu RT: Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease. J Neuroinflammation. 18:1312021. View Article : Google Scholar : PubMed/NCBI

Bernard CB, Krishanmurty HG, Chauret D, Durst T, Philogène BJ, Sánchez-Vindas P, Hasbun C, Poveda L, San Román L and Arnason JT: Insecticidal defenses of piperaceae from the neotropics. J Chem Ecol. 21:801–814. 1995. View Article : Google Scholar : PubMed/NCBI

Gu SM, Lee HP, Ham YW, Son DJ, Kim HY, Oh KW, Han SB, Yun J and Hong JT: Piperlongumine improves lipopolysaccharide-induced amyloidogenesis by suppressing NF-KappaB pathway. Neuromolecular Med. 20:312–327. 2018. View Article : Google Scholar : PubMed/NCBI

Son DJ, Lee JW, Lee YH, Song HS, Lee CK and Hong JT: Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115:246–270. 2007. View Article : Google Scholar : PubMed/NCBI

Gu SM, Park MH, Hwang CJ, Song HS, Lee US, Han SB, Oh KW, Ham YW, Song MJ, Son DJ and Hong JT: Bee venom ameliorates lipopolysaccharide-induced memory loss by preventing NF-kappaB pathway. J Neuroinflammation. 12:1242015. View Article : Google Scholar : PubMed/NCBI

Lin CC, Hsu YF and Lin TC: Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats. Am J Chin Med. 27:371–376. 1999. View Article : Google Scholar : PubMed/NCBI

Kim YE, Hwang CJ, Lee HP, Kim CS, Son DJ, Ham YW, Hellström M, Han SB, Kim HS, Park EK and Hong JT: Inhibitory effect of punicalagin on lipopolysaccharide-induced neuroinflammation, oxidative stress and memory impairment via inhibition of nuclear factor-kappaB. Neuropharmacology. 117:21–32. 2017. View Article : Google Scholar : PubMed/NCBI

Chen S and Jia J: Tenuifolin attenuates amyloid-β42-induced neuroinflammation in microglia through the NF-κB signaling pathway. J Alzheimers Dis. 76:195–205. 2020. View Article : Google Scholar

Hammad AS, Ravindran S, Khalil A and Munusamy S: Structure-activity relationship of piperine and its synthetic amide analogs for therapeutic potential to prevent experimentally induced ER stress in vitro. Cell Stress Chaperones. 22:417–428. 2017. View Article : Google Scholar : PubMed/NCBI

Shahbazi S, Zakerali T, Frycz B and Kaur J: Impact of novel N-aryl substituted piperamide on NF-kappa B translocation as a potent anti-neuroinflammatory agent. Biomed Pharmacother. 127:1101992020. View Article : Google Scholar : PubMed/NCBI

Shahbazi S, Zakerali T, Frycz BA and Kaur J: The critical role of piperamide derivative D4 in the regulation of inflammatory response by the microglia and astrocytic glial cells. Biomed Pharmacother. 132:1108952020. View Article : Google Scholar : PubMed/NCBI

Hsu YL, Kuo PL, Chiang LC and Lin CC: Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines. Cancer Lett. 213:213–221. 2004. View Article : Google Scholar : PubMed/NCBI

Park WH, Kang S, Piao Y, Pak CJ, Oh MS, Kim J, Kang MS and Pak YK: Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB. J Ethnopharmacol. 174:37–44. 2015. View Article : Google Scholar : PubMed/NCBI

Leláková V, Béraud-Dufour S, Hošek J, Šmejkal K, Prachyawarakorn V, Pailee P, Widmann C, Václavík J, Coppola T, Mazella J, et al: Therapeutic potential of prenylated stilbenoid macasiamenene F through its anti-inflammatory and cytoprotective effects on LPS-challenged monocytes and microglia. J Ethnopharmacol. 263:1131472020. View Article : Google Scholar : PubMed/NCBI

Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, et al: Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 522:216–220. 2015. View Article : Google Scholar : PubMed/NCBI

Yeo IJ, Yun J, Son DJ, Han SB and Hong JT: Antifungal drug miconazole ameliorated memory deficits in a mouse model of LPS-induced memory loss through targeting iNOS. Cell Death Dis. 11:6232020. View Article : Google Scholar : PubMed/NCBI

Solberg NO, Chamberlin R, Vigil JR, Deck LM, Heidrich JE, Brown DC, Brady CI, Vander Jagt TA, Garwood M, Bisoffi M, et al: Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain. J Alzheimers Dis. 40:191–212. 2014. View Article : Google Scholar

Lindsay A, Hickman D and Srinivasan M: A nuclear factor-kappa B inhibiting peptide suppresses innate immune receptors and gliosis in a transgenic mouse model of Alzheimer's disease. Biomed Pharmacother. 138:1114052021. View Article : Google Scholar : PubMed/NCBI

Choi JY, Yeo IJ, Kim KC, Choi WR, Jung JK, Han SB and Hong JT: K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression. J Neuroinflammation. 15:2242018. View Article : Google Scholar

Lian W, Jia H, Xu L, Zhou W, Kang D, Liu A and Du G: Multi-protection of DL0410 in ameliorating cognitive defects in D-galactose induced aging mice. Front Aging Neurosci. 9:4092017. View Article : Google Scholar : PubMed/NCBI

Heynekamp JJ, Weber WM, Hunsaker LA, Gonzales AM, Orlando RA, Deck LM and Jagt DL: Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J Med Chem. 49:7182–7189. 2006. View Article : Google Scholar : PubMed/NCBI

Ayroldi E and Riccardi C: Glucocorticoid-induced leucine zipper (GILZ): A new important mediator of glucocorticoid action. FASEB J. 23:3649–3658. 2009. View Article : Google Scholar : PubMed/NCBI

Cannarile L, Zollo O, D'Adamio F, Ayroldi E, Marchetti C, Tabilio A, Bruscoli S and Riccardi C: Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ. 8:201–203. 2001. View Article : Google Scholar : PubMed/NCBI

Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL and Wiley CA: In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation. 7:342010. View Article : Google Scholar : PubMed/NCBI

Muszyński P, Groblewska M, Kulczyńska-Przybik A, Kułakowska A and Mroczko B: YKL-40 as a potential biomarker and a possible target in therapeutic strategies of Alzheimer's disease. Curr Neuropharmacol. 15:906–917. 2017. View Article : Google Scholar

Di Rosa M and Malaguarnera L: Chitinase 3 like-1: An emerging molecule involved in diabetes and diabetic complications. Pathobiology. 83:228–242. 2016. View Article : Google Scholar : PubMed/NCBI

Billod JM, Lacetera A, Guzmán-Caldentey J and Martín-Santamaría S: Computational approaches to Toll-like receptor 4 modulation. Molecules. 21:9942016. View Article : Google Scholar : PubMed/NCBI

Mertowski S, Grywalska E, Gosik K, Smarz-Widelska I, Hymos A, Dworacki G, Niedźwiedzka-Rystwej P, Drop B, Roliński J and Załuska W: TLR2 expression on select lymphocyte subsets as a new marker in glomerulonephritis. J Clin Med. 9:5412020. View Article : Google Scholar : PubMed/NCBI

Elmaidomy AH, Alhadrami HA, Amin E, Aly HF, Othman AM, Rateb ME, Hetta MH, Abdelmohsen UR and M Hassan H: Anti-inflammatory and antioxidant activities of terpene- and polyphenol-rich premna odorata leaves on alcohol-inflamed female wistar albino rat liver. Molecules. 25:31162020. View Article : Google Scholar : PubMed/NCBI

Zhong X, Liu M, Yao W, Du K, He M, Jin X, Jiao L, Ma G, Wei B and Wei M: Epigallocatechin-3-gallate attenuates microglial inflammation and neurotoxicity by suppressing the activation of canonical and noncanonical inflammasome via TLR4/NF-κB pathway. Mol Nutr Food Res. 63:e18012302019. View Article : Google Scholar

Zhou X, Yuan L, Zhao X, Hou C, Ma W, Yu H and Xiao R: Genistein antagonizes inflammatory damage induced by β-amyloid peptide in microglia through TLR4 and NF-κB. Nutrition. 30:90–95. 2014. View Article : Google Scholar

Chen R, Wang Z, Zhi Z, Tian J, Zhao Y and Sun J: Targeting the TLR4/NF-κB pathway in β-amyloid-stimulated microglial cells: A possible mechanism that oxysophoridine exerts anti-oxidative and anti-inflammatory effects in an in vitro model of Alzheimer's disease. Brain Res Bull. 175:150–157. 2021. View Article : Google Scholar : PubMed/NCBI

Onishi S, Meguro S, Pervin M, Kitazawa H, Yoto A, Ishino M, Shimba Y, Mochizuki Y, Miura S, Tokimitsu I and Unno K: Green tea extracts attenuate brain dysfunction in high-fat-diet-fed SAMP8 mice. Nutrients. 11:8212019. View Article : Google Scholar : PubMed/NCBI

Balázs A, Faisal Z, Csepregi R, Kőszegi T, Kriszt B, Szabó I and Poór M: In Vitro evaluation of the individual and combined cytotoxic and estrogenic effects of zearalenone, its reduced metabolites, alternariol, and genistein. Int J Mol Sci. 22:62812021. View Article : Google Scholar : PubMed/NCBI

Wang R, Deng X, Gao Q, Wu X, Han L, Gao X, Zhao S, Chen W, Zhou R, Li Z and Bai C: Sophora alopecuroides L.: An ethnopharmacological, phytochemical, and pharmacological review. J Ethnopharmacol. 248:1121722020. View Article : Google Scholar

Rui C, Yuxiang L, Ning J, Ningtian M, Qingluan Z, Yinju H, Ru Z, Lin M, Tao S and Jianqiang Y: Anti-apoptotic and neuroprotective effects of oxysophoridine on cerebral ischemia both in vivo and in vitro. Planta Med. 79:916–923. 2013. View Article : Google Scholar : PubMed/NCBI

Wang Y, Wang Y, Jia S, Dong Q, Chen Y, Lu S and Hou L: Effect of lipid-bound apolipoprotein A-I cysteine mutant on ATF3 in RAW264.7 cells. Biosci Rep. 37:BSR201603982017. View Article : Google Scholar : PubMed/NCBI

Zeng KW, Zhao MB, Ma ZZ, Jiang Y and Tu PF: Protosappanin A inhibits oxidative and nitrative stress via interfering the interaction of transmembrane protein CD14 with Toll-like receptor-4 in lipopolysaccharide-induced BV-2 microglia. Int Immunopharmacol. 14:558–569. 2012. View Article : Google Scholar : PubMed/NCBI

Mo Y, Sun YY and Liu KY: Autophagy and inflammation in ischemic stroke. Neural Regen Res. 15:1388–1396. 2020. View Article : Google Scholar : PubMed/NCBI

Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P and Marambaud P: Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. J Neurochem. 120:461–472. 2012. View Article : Google Scholar

Xu Y, Huang X, Huangfu B, Hu Y, Xu J, Gao R, Huang K and He X: Sulforaphane ameliorates nonalcoholic fatty liver disease induced by high-fat and high-fructose diet via LPS/TLR4 in the gut-liver axis. Nutrients. 15:7432023. View Article : Google Scholar : PubMed/NCBI

Song J, Feng L, Zhong R, Xia Z, Zhang L, Cui L, Yan H, Jia X and Zhang Z: Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway. Mol Carcinogen. 56:36–48. 2017. View Article : Google Scholar

Lee KS, Lee HJ, Ahn KS and Kim SH, Nam D, Kim DK, Choi DY, Ahn KS, Lu J and Kim SH: Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett. 280:93–100. 2009. View Article : Google Scholar : PubMed/NCBI

Zhou J, Deng Y, Li F, Yin C, Shi J and Gong Q: Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-κB pathway in rats. Biomed Pharmacother. 111:315–324. 2019. View Article : Google Scholar

Zhou D, Zhou W, Song JK, Feng ZY, Yang RY, Wu S, Wang L, Liu AL and Du GH: DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway. Acta Pharmacol Sin. 37:1401–1412. 2016. View Article : Google Scholar : PubMed/NCBI

Yang RY, Zhao G, Wang DM, Pang XC, Wang SB, Fang JS, Li C, Liu AL, Wu S and Du GH: DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice. Pharmacol Biochem Behav. 139:15–26. 2015. View Article : Google Scholar : PubMed/NCBI

Zhang B, Lian W, Zhao J, Wang Z, Liu A and Du G: DL0410 Alleviates memory impairment in D-galactose-induced aging rats by suppressing neuroinflammation via the TLR4/MyD88/NF-κB pathway. Oxid Med Cell Longev. 2021:65211462021.

Mao J, Huang S, Liu S, Feng XL, Yu M, Liu J, Sun YE, Chen G, Yu Y, Zhao J and Pei G: A herbal medicine for Alzheimer's disease and its active constituents promote neural progenitor proliferation. Aging Cell. 14:784–796. 2015. View Article : Google Scholar : PubMed/NCBI

Geng Y, Li C, Liu J, Xing G, Zhou L, Dong M, Li X and Niu Y: Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats. Biol Pharm Bull. 33:836–843. 2010. View Article : Google Scholar : PubMed/NCBI

Zhong J, Qiu X, Yu Q, Chen H and Yan C: A novel polysaccharide from Acorus tatarinowii protects against LPS-induced neuroinflammation and neurotoxicity by inhibiting TLR4-mediated MyD88/NF-κB and PI3K/Akt signaling pathways. Int J Biol Macromol. 163:464–475. 2020. View Article : Google Scholar : PubMed/NCBI

Liu M, Guo H, Li Z, Zhang C, Zhang X, Cui Q and Tian J: Molecular level insight into the benefit of myricetin and dihydromyricetin uptake in patients with Alzheimer's diseases. Front Aging Neurosci. 12:6016032020. View Article : Google Scholar : PubMed/NCBI

Jing N and Li X: Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway. Open Med (Wars). 14:719–725. 2019. View Article : Google Scholar : PubMed/NCBI

Gu RX, Gu H, Xie ZY, Wang JF, Arias HR, Wei DQ and Chou KC: Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor. Med Chem. 5:250–262. 2009. View Article : Google Scholar : PubMed/NCBI

Shi S, Liang D, Chen Y, Xie Y, Wang Y, Wang L, Wang Z and Qiao Z: Gx-50 reduces β-amyloid-induced TNF-α, IL-1β, NO, and PGE2 expression and inhibits NF-κB signaling in a mouse model of Alzheimer's disease. Eur J Immunol. 46:665–676. 2016. View Article : Google Scholar

Zheng P, Huang C, Leng D, Sun B and Zhang XD: Transcriptome analysis of peripheral whole blood identifies crucial lncRNAs implicated in childhood asthma. Bmc Med Genomics. 13:1362020. View Article : Google Scholar : PubMed/NCBI

Zhong X, Feng L, Xu WH, Wu X, Ding YD, Zhou Y, Lei CQ and Shu HB: The zinc-finger protein ZFYVE1 modulates TLR3-mediated signaling by facilitating TLR3 ligand binding. Cell Mol Immunol. 17:741–752. 2020. View Article : Google Scholar :

Wang Z, Xia Q, Liu X, Liu W, Huang W, Mei X, Luo J, Shan M, Lin R, Zou D and Ma Z: Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: A review. J Ethnopharmacol. 210:318–339. 2018. View Article : Google Scholar

Kong F, Jiang X, Wang R, Zhai S, Zhang Y and Wang D: Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease. J Neuroinflammation. 17:3052020. View Article : Google Scholar

Lu TC, Wu YH, Chen WY and Hung YC: Targeting oxidative stress and endothelial dysfunction using tanshinone IIA for the treatment of tissue inflammation and fibrosis. Oxid Med Cell Longev. 2022:28117892022. View Article : Google Scholar : PubMed/NCBI

Lu BL, Li J, Zhou J, Li WW and Wu HF: Tanshinone IIA decreases the levels of inflammation induced by Aβ1-42 in brain tissues of Alzheimer's disease model rats. Neuroreport. 27:883–893. 2016. View Article : Google Scholar : PubMed/NCBI

Jiang P, Li C, Xiang Z and Jiao B: Tanshinone IIA reduces the risk of Alzheimer's disease by inhibiting iNOS, MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease. Mol Med Rep. 10:689–694. 2014. View Article : Google Scholar : PubMed/NCBI

Maione F, Piccolo M, De Vita S, Chini MG, Cristiano C, De Caro C, Lippiello P, Miniaci MC, Santamaria R, Irace C, et al: Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's disease. Pharmacol Res. 129:482–490. 2018. View Article : Google Scholar

Ding B, Lin C, Liu Q, He Y, Ruganzu JB, Jin H, Peng X, Ji S, Ma Y and Yang W: Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro. J Neuroinflammation. 17:3022020. View Article : Google Scholar

Xing L, Tan ZR, Cheng JL, Huang WH, Zhang W, Deng W, Yuan CS and Zhou HH: Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of Salvia miltiorrhiza in healthy volunteers. Sci Rep. 7:47092017. View Article : Google Scholar : PubMed/NCBI

Hu X, Zhang J, Deng L, Hu H, Hu J and Zheng G: Galactose-modified PH-sensitive niosomes for controlled release and hepatocellular carcinoma target delivery of tanshinone IIA. AAPS PharmSciTech. 22:962021. View Article : Google Scholar : PubMed/NCBI

Zhang X, Kang X, Du L, Zhang L, Huang Y, Wang J, Wang S, Chang Y, Liu Y and Zhao Y: Tanshinone IIA loaded chitosan nanoparticles decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of disease. Free Radical Bio Med. 193:81–94. 2022. View Article : Google Scholar

Thundyil J, Pavlovski D, Sobey CG and Arumugam TV: Adiponectin receptor signalling in the brain. Brit J Pharmacol. 165:313–327. 2012. View Article : Google Scholar

Ng RC, Cheng OY, Jian M, Kwan JS, Ho PW, Cheng KK, Yeung PK, Zhou LL, Hoo RL, Chung SK, et al: Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice. Mol Neurodegener. 11:712016. View Article : Google Scholar : PubMed/NCBI

Boza-Serrano A, Yang Y, Paulus A and Deierborg T: Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD. Sci Rep. 8:15502018. View Article : Google Scholar : PubMed/NCBI

Jian M, Kwan JSC, Bunting M, Ng RCL and Chan KH: Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway. J Neuroinflammation. 16:1102019. View Article : Google Scholar

Chen X, Su J, Wang R, Hao R, Fu C, Chen J, Li J and Wang X: Structural optimization of cannabidiol as multifunctional cosmetic raw materials. Antioxidants (Basel). 12:3142023. View Article : Google Scholar : PubMed/NCBI

Malakoti F, Targhazeh N, Abadifard E, Zarezadeh R, Samemaleki S, Asemi Z, Younesi S, Mohammadnejad R, Hadi Hossini S, Karimian A, et al: DNA repair and damage pathways in mesothelioma development and therapy. Cancer Cell Int. 22:1762022. View Article : Google Scholar : PubMed/NCBI

Schiffmann SN and Vanderhaeghen JJ: Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system. J Comp Neurol. 304:219–233. 1991. View Article : Google Scholar : PubMed/NCBI

Hensley K, Floyd RA, Zheng NY, Nael R, Robinson KA, Nguyen X, Pye QN, Stewart CA, Geddes J, Markesbery WR, et al: p38 kinase is activated in the Alzheimer's disease brain. J Neurochem. 72:2053–2058. 1999. View Article : Google Scholar : PubMed/NCBI

Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H and Smith MA: Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem. 76:435–441. 2001. View Article : Google Scholar : PubMed/NCBI

Jin Y, Yan EZ, Fan Y, Zong ZH, Qi ZM and Li Z: Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharmacol Sin. 26:943–951. 2005. View Article : Google Scholar : PubMed/NCBI

McDonald DR, Bamberger ME, Combs CK and Landreth GE: beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci. 18:4451–4460. 1998. View Article : Google Scholar : PubMed/NCBI

Koistinaho M and Koistinaho J: Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia. 40:175–183. 2002. View Article : Google Scholar : PubMed/NCBI

Kim SH, Smith CJ and Van Eldik LJ: Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging. 25:431–439. 2004. View Article : Google Scholar : PubMed/NCBI

Liang Z, Zhang B, Xu M, Morisseau C, Hwang SH, Hammock BD and Li QX: 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, a selective and potent dual inhibitor of soluble epoxide hydrolase and p38 kinase intervenes in Alzheimer's signaling in human nerve cells. ACS Chem Neurosci. 10:4018–4030. 2019. View Article : Google Scholar : PubMed/NCBI

Chang D, Li H, Qian C and Wang Y: DiOHF protects against doxorubicin-induced cardiotoxicity through ERK1 signaling pathway. Front Pharmacol. 10:10812019. View Article : Google Scholar : PubMed/NCBI

Lee HC, Yu HP, Liao CC, Chou AH and Liu FC: Escin protects against acetaminophen-induced liver injury in mice via attenuating inflammatory response and inhibiting ERK signaling pathway. Am J Transl Res. 11:5170–5182. 2019.PubMed/NCBI

Sclip A, Tozzi A, Abaza A, Cardinetti D, Colombo I, Calabresi P, Salmona M, Welker E and Borsello T: c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo. Cell Death Dis. 5:e10192014. View Article : Google Scholar : PubMed/NCBI

Jeong YH, Li W, Go Y and Oh YC: Atractylodis rhizoma alba attenuates neuroinflammation in BV2 microglia upon LPS stimulation by inducing HO-1 activity and inhibiting NF-κB and MAPK. Int J Mol Sci. 20:40152019. View Article : Google Scholar

Dang TK, Hong SM, Dao VT, Tran PTT, Tran HT, Do GH, Hai TN, Nguyet Pham HT and Kim SY: Anti-neuroinflammatory effects of alkaloid-enriched extract from Huperzia serrata on lipopolysaccharide-stimulated BV-2 microglial cells. Pharm Biol. 61:135–143. 2023. View Article : Google Scholar : PubMed/NCBI

Sun A, Liu M, Nguyen XV and Bing G: P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp Neurol. 183:394–405. 2003. View Article : Google Scholar : PubMed/NCBI

Schnöder L, Hao W, Qin Y, Liu S, Tomic I, Liu X, Fassbender K and Liu Y: Deficiency of neuronal p38α MAPK attenuates amyloid pathology in Alzheimer disease mouse and cell models through facilitating lysosomal degradation of BACE1. J Biol Chem. 291:2067–2079. 2016. View Article : Google Scholar

Wu H, Hu B, Zhou X, Zhou C, Meng J, Yang Y, Zhao X, Shi Z and Yan S: Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway. Cell Death Dis. 9:4982018. View Article : Google Scholar : PubMed/NCBI

Xing B, Bachstetter AD and Van Eldik LJ: Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα. Mol Neurodegener. 6:842011. View Article : Google Scholar

Munoz L, Ralay Ranaivo H, Roy SM, Hu W, Craft JM, McNamara LK, Chico LW, Van Eldik LJ and Watterson DM: A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. J Neuroinflammation. 4:212007. View Article : Google Scholar : PubMed/NCBI

Maphis N, Jiang S, Xu G, Kokiko-Cochran ON, Roy SM, Van Eldik LJ, Watterson DM, Lamb BT and Bhaskar K: Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology. Alzheimers Res Ther. 8:542016. View Article : Google Scholar

Haddad JJ: VX-745. Vertex pharmaceuticals. Curr Opin Investig Drugs. 2:1070–1076. 2001.

Alam JJ: Selective brain-targeted antagonism of p38 MAPKα reduces hippocampal IL-1β levels and improves morris water maze performance in aged rats. J Alzheimers Dis. 48:219–227. 2015. View Article : Google Scholar

Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A and Gaestel M: Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol. 26:2399–2407. 2006. View Article : Google Scholar : PubMed/NCBI

Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Seymour ZM, Guillot F, Gaestel M and Richardson JC: MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem. 281:23658–23667. 2006. View Article : Google Scholar : PubMed/NCBI

Brugnano JL, Chan BK, Seal BL and Panitch A: Cell-penetrating peptides can confer biological function: regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides. J Control Release. 155:128–133. 2011. View Article : Google Scholar : PubMed/NCBI

Jiang J, Wang Z, Liang X, Nie Y, Chang X, Xue H, Li S and Min C: Intranasal MMI-0100 attenuates Aβ_1-42 - and LPS-induced neuroinflammation and memory impairments via the MK2 signaling pathway. Front Immunol. 10:27072019. View Article : Google Scholar

Mittal D, Ali A, Md S, Baboota S, Sahni JK and Ali J: Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv. 21:75–86. 2014. View Article : Google Scholar

Mistry A, Stolnik S and Illum L: Nose-to-brain delivery: Investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium. Mol Pharm. 12:2755–2766. 2015. View Article : Google Scholar : PubMed/NCBI

Zakaria ZA, Patahuddin H, Mohamad AS, Israf DA and Sulaiman MR: In vivo anti-nociceptive and anti-inflammatory activities of the aqueous extract of the leaves of Piper sarmentosum. J Ethnopharmacol. 128:42–48. 2010. View Article : Google Scholar

Chan EWL, Yeo ETY, Wong KWL, See ML, Wong KY and Gan SY: Piper sarmentosum Roxb. Root extracts confer neuroprotection by attenuating beta amyloid-induced pro-inflammatory cytokines released from microglial cells. Curr Alzheimer Res. 16:251–260. 2019. View Article : Google Scholar : PubMed/NCBI

Wang X, Zhao X and Tang S: Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction. Cell Stress Chaperon. 20:781–786. 2015. View Article : Google Scholar

Meng M, Ai D, Sun L, Xu X and Cao X: EGb 761 inhibits Aβ1-42-induced neuroinflammatory response by suppressing P38 MAPK signaling pathway in BV-2 microglial cells. Neuroreport. 30:434–440. 2019. View Article : Google Scholar : PubMed/NCBI

Marchand G, Wambang N, Pellegrini S, Molinaro C, Martoriati A, Bousquet T, Markey A, Lescuyer-Rousseau A, Bodart JF, Cailliau K, et al: Effects of ferrocenyl 4-(Imino)-1,4-dihydro-quinolines on xenopus laevis prophase I-arrested oocytes: Survival and hormonal-induced M-phase entry. Int J Mol Sci. 21:30492020. View Article : Google Scholar

Chiu YJ, Hsieh YH, Lin TH, Lee GC, Hsieh-Li HM, Sun YC, Chen CM, Chang KH and Lee-Chen GJ: Novel compound VB-037 inhibits Aβ aggregation and promotes neurite outgrowth through enhancement of HSP27 and reduction of P38 and JNK-mediated inflammation in cell models for Alzheimer's disease. Neurochem Int. 125:175–186. 2019. View Article : Google Scholar : PubMed/NCBI

Czarnecka K, Girek M, Maciejewska K, Skibiński R, Jończyk J, Bajda M, Kabziński J, Sołowiej P, Majsterek I and Szymański P: New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease. J Enzym Inhib Med Chem. 33:158–170. 2017. View Article : Google Scholar

Olajide OA, Bhatia HS, de Oliveira AC, Wright CW and Fiebich BL: Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine. Evid Based Complement Alternat Med. 2013:4597232013. View Article : Google Scholar : PubMed/NCBI

Castro-Torres RD, Busquets O, Parcerisas A, Verdaguer E, Olloquequi J, Ettcheto M, Beas-Zarate C, Folch J, Camins A and Auladell C: Involvement of JNK1 in neuronal polarization during brain development. Cells. 9:18972020. View Article : Google Scholar : PubMed/NCBI

Ma Z, Zang T, Birnbaum SG, Wang Z, Johnson JE, Zhang CL and Parada LF: TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response. Nat Commun. 8:16682017. View Article : Google Scholar : PubMed/NCBI

Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y and Hu LL: ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 19:1997–2007. 2020.PubMed/NCBI

Paquet C, Nicoll JA, Love S, Mouton-Liger F, Holmes C, Hugon J and Boche D: Downregulated apoptosis and autophagy after anti-Aβ immunotherapy in Alzheimer's disease. Brain Pathol. 28:603–610. 2018. View Article : Google Scholar

Yuan Y, Chen J, Ge X, Deng J, Xu X, Zhao Y and Wang H: Activation of ERK-Drp1 signaling promotes hypoxia-induced Aβ accumulation by upregulating mitochondrial fission and BACE1 activity. Febs Open Bio. 11:2740–2755. 2021. View Article : Google Scholar : PubMed/NCBI

Ho WC, Hsu CC, Huang HJ, Wang HT and Lin AMY: Anti-inflammatory effect of AZD6244 on acrolein-induced neuroinflammation. Mol Neurobiol. 57:88–95. 2020. View Article : Google Scholar

Qiu Z, Lu P, Wang K, Zhao X, Li Q, Wen J, Zhang H, Li R, Wei H, Lv Y, et al: Dexmedetomidine inhibits neuroinflammation by altering microglial M1/M2 polarization through MAPK/ERK pathway. Neurochem Res. 45:345–353. 2020. View Article : Google Scholar

Goldfarb G, Doan Ba Tri and Duran A: Human placenta for chronic leg ulcers. Lancet. 2:401980. View Article : Google Scholar : PubMed/NCBI

Lee KW, Ji HM, Kim DW, Choi SM, Kim S and Yang EJ: Effects of Hominis placenta on LPS-induced cell toxicity in BV2 microglial cells. J Ethnopharmacol. 147:286–292. 2013. View Article : Google Scholar : PubMed/NCBI

Filocamo A, Bisignano C, Ferlazzo N, Cirmi S, Mandalari G and Navarra M: In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori. BMC Complement Altern Med. 15:2562015. View Article : Google Scholar : PubMed/NCBI

Currò M, Risitano R, Ferlazzo N, Cirmi S, Gangemi C, Caccamo D, Ientile R and Navarra M: Citrus bergamia juice extract attenuates β-amyloid-induced pro-inflammatory activation of THP-1 cells through MAPK and AP-1 pathways. Sci Rep. 6:208092016. View Article : Google Scholar

Eglitis MA and Mezey E: Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA. 94:4080–4085. 1997. View Article : Google Scholar : PubMed/NCBI

Hickey WF and Kimura H: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239:290–292. 1988. View Article : Google Scholar : PubMed/NCBI

Tao M, Zheng D, Liang X, Wu D, Hu K, Jin J and He Q: Tripterygium glycoside suppresses epithelial-to-mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway. Mol Med Rep. 24:5922021. View Article : Google Scholar :

Tang L, Xiang Q, Xiang J, Zhang Y and Li J: Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Aβ25-35-induced Alzheimer's disease by inhibiting the phosphorylation of IκBα and p38. Bioengineered. 12:8540–8554. 2021. View Article : Google Scholar : PubMed/NCBI

Cao X, Jin Y, Zhang H, Yu L, Bao X, Li F and Xu Y: The antiinflammatory effects of 4-[(5-Bromo-3-chloro-2-hydroxybenzyl) amino]-2-hydroxybenzoic acid in lipopolysaccharide-activated primary microglial cells. Inflammation. 41:530–540. 2018. View Article : Google Scholar

Kim ME, Jung I, Na JY, Lee Y, Lee J and Lee JS and Lee JS: Pseudane-VII regulates LPS-induced neuroinflammation in brain microglia cells through the inhibition of iNOS expression. Molecules. 23:31962018. View Article : Google Scholar : PubMed/NCBI

Zhao H, Wang SL, Qian L, Jin JL, Li H, Xu Y and Zhu XL: Diammonium glycyrrhizinate attenuates Aβ(1-42)-induced neuroinflammation and regulates MAPK and NF-κB pathways in vitro and in vivo. CNS Neurosci Ther. 19:117–124. 2013. View Article : Google Scholar : PubMed/NCBI

Ramana KV and Srivastava SK: Aldose reductase: A novel therapeutic target for inflammatory pathologies. Int J Biochem Cell Biol. 42:17–20. 2010. View Article : Google Scholar

Song XM, Yu Q, Dong X, Yang HO, Zeng KW, Li J and Tu PF: Aldose reductase inhibitors attenuate β-amyloid-induced TNF-α production in microlgia via ROS-PKC-mediated NF-κB and MAPK pathways. Int Immunopharmacol. 50:30–37. 2017. View Article : Google Scholar : PubMed/NCBI

Meza CA, La Favor JD, Kim DH and Hickner RC: Endothelial dysfunction: Is there a hyperglycemia-induced imbalance of NOX and NOS? Int J Mol Sci. 20:37752019. View Article : Google Scholar : PubMed/NCBI

Lee J, Narayan VP, Hong EY, Whang WK and Park T: Artemisia iwayomogi extract attenuates high-fat diet-induced hypertriglyceridemia in mice: Potential involvement of the adiponectin-AMPK pathway and very low density lipoprotein assembly in the liver. Int J Mol Sci. 18:17622017. View Article : Google Scholar : PubMed/NCBI

Ju IG, Huh E, Kim N, Lee S, Choi JG, Hong J and Oh MS: Artemisiae iwayomogii herba inhibits lipopolysaccharide-induced neuroinflammation by regulating NF-κB and MAPK signaling pathways. Phytomedicine. 84:1535012021. View Article : Google Scholar

Hilliard A, Mendonca P and Soliman KFA: Involvement of NFkB and MAPK signaling pathways in the preventive effects of Ganoderma lucidum on the inflammation of BV-2 microglial cells induced by LPS. J Neuroimmunol. 345:5772692020. View Article : Google Scholar

Cheung WM, Hui WS, Chu PW, Chiu SW and Ip NY: Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells. FEBS Lett. 486:291–296. 2000. View Article : Google Scholar : PubMed/NCBI

Geng X, Zhong D, Su L and Yang B: Preventive and therapeutic effect of ganoderma (Lingzhi) on renal diseases and clinical applications. Adv Exp Med Biol. 1182:243–262. 2019. View Article : Google Scholar : PubMed/NCBI

Chen LG, Jan YS, Tsai PW, Norimoto H, Michihara S, Murayama C and Wang CC: Anti-inflammatory and antinociceptive constituents of atractylodes japonica koidzumi. J Agric Food Chem. 64:2254–2262. 2016. View Article : Google Scholar : PubMed/NCBI

Tang JJ, Wang MR, Dong S, Huang LF, He QR and Gao JM: 1,10-Seco-Eudesmane sesquiterpenoids as a new type of anti-neuroinflammatory agents by suppressing TLR4/NF-κB/MAPK pathways. Eur J Med Chem. 224:1137132021. View Article : Google Scholar

Choi MS, Jung UJ, Kim HJ, Do GM, Jeon SM, Kim MJ and Lee MK: Du-zhong (Eucommia ulmoides Oliver) leaf extract mediates hypolipidemic action in hamsters fed a high-fat diet. Am J Chin Med. 36:81–93. 2008. View Article : Google Scholar : PubMed/NCBI

He X, Wang J, Li M, Hao D, Yang Y, Zhang C, He R and Tao R: Eucommia ulmoides Oliv.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol. 151:78–92. 2014. View Article : Google Scholar

Han R, Yuan T, Yang Z, Zhang Q, Wang WW, Lin LB, Zhu MQ and Gao JM: Ulmoidol, an unusual nortriterpenoid from Eucommia ulmoides Oliv. Leaves prevents neuroinflammation by targeting the PU.1 transcriptional signaling pathway. Bioorg Chem. 116:1053452021. View Article : Google Scholar : PubMed/NCBI

Zhang C, Hu L, Liu D, Huang J and Lin W: Circumdatin D exerts neuroprotective effects by attenuating LPS-induced pro-inflammatory responses and downregulating acetylcholinesterase activity in vitro and in vivo. Front Pharmacol. 11:7602020. View Article : Google Scholar : PubMed/NCBI

Gong P, Deng F, Zhang W, Ji J, Liu J, Sun Y and Hu J: Tectorigenin attenuates the MPP⁺-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition. Exp Ther Med. 14:4431–4437. 2017.PubMed/NCBI

Oh KB, Kang H and Matsuoka H: Detection of antifungal activity in Belamcanda chinensis by a single-cell bioassay method and isolation of its active compound, tectorigenin. Biosci Biotechnol Biochem. 65:939–942. 2001. View Article : Google Scholar : PubMed/NCBI

Lim HS, Kim YJ, Kim BY, Park G and Jeong SJ: The Anti-neuroinflammatory activity of tectorigenin pretreatment via downregulated NF-κB and ERK/JNK pathways in BV-2 microglial and microglia inactivation in mice with lipopolysaccharide. Front Pharmacol. 9:4622018. View Article : Google Scholar

Wang BR, Shi JQ, Ge NN, Ou Z, Tian YY, Jiang T, Zhou JS, Xu J and Zhang YD: PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer's disease. J Neuroinflammation. 15:1322018. View Article : Google Scholar : PubMed/NCBI

Shao BZ, Xu ZQ, Han BZ, Su DF and Liu C: NLRP3 inflammasome and its inhibitors: A review. Front Pharmacol. 6:2622015. View Article : Google Scholar : PubMed/NCBI

Feng YS, Tan ZX, Wu LY, Dong F and Zhang F: The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease. Ageing Res Rev. 64:1011922020. View Article : Google Scholar : PubMed/NCBI

Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, et al: NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 493:674–678. 2013. View Article : Google Scholar

Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ and Golenbock DT: The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 9:857–865. 2008. View Article : Google Scholar : PubMed/NCBI

Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D'Alessandro A, Dinarello CA and Korte M: The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 117:32145–32154. 2020. View Article : Google Scholar : PubMed/NCBI

Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T, Carta S, Tengesdal I, Nemkov T, D'Alessandro A, et al: OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci USA. 115:E1530–E1539. 2018. View Article : Google Scholar

Klück V, Jansen TLTA, Janssen M, Comarniceanu A, Efdé M, Tengesdal IW, Schraa K, Cleophas MCP, Scribner CL, Skouras DB, et al: Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: An open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2:e270–e280. 2020. View Article : Google Scholar : PubMed/NCBI

Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O'Neill LAJ and Lynch MA: Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Brain Behav Immun. 61:306–316. 2017. View Article : Google Scholar

Fekete C, Vastagh C, Dénes Á, Hrabovszky E, Nyiri G, Kalló I, Liposits Z and Sárvári M: Chronic amyloid β oligomer infusion evokes sustained inflammation and microglial changes in the rat hippocampus via NLRP3. Neuroscience. 405:35–46. 2019. View Article : Google Scholar

Kuwar R, Rolfe A, Di L, Blevins H, Xu Y, Sun X, Bloom GS, Zhang S and Sun D: A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in Alzheimer's disease transgenic mice. J Alzheimers Dis. 82:1769–1783. 2021. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Zhao Y, Zhang J, Gao Y, Li S, Chang C, Yu D and Yang G: Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ_1-42 -induced microglia cells. Neurosci Lett. 764:1362062021. View Article : Google Scholar

Gu JH, Ge JB, Li M, Wu F, Zhang W and Qin ZH: Inhibition of NF-κB activation is associated with anti-inflammatory and anti-apoptotic effects of ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury. Eur J Pharm Sci. 47:652–660. 2012. View Article : Google Scholar : PubMed/NCBI

Kaur N, Dhiman M, Perez-Polo JR and Mantha AK: Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ25-35-induced neurotoxicity in human neuroblastoma cells. J Neurosci Res. 93:938–947. 2015. View Article : Google Scholar : PubMed/NCBI

Zhang HR, Peng JH, Cheng XB, Shi BZ, Zhang MY and Xu RX: Paeoniflorin atttenuates amyloidogenesis and the inflammatory responses in a transgenic mouse model of Alzheimer's disease. Neurochem Res. 40:1583–1592. 2015. View Article : Google Scholar : PubMed/NCBI

Liu HQ, Zhang WY, Luo XT, Ye Y and Zhu XZ: Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Brit J Pharmacol. 148:314–325. 2006. View Article : Google Scholar

Liu DZ, Xie KQ, Ji XQ, Ye Y, Jiang CL and Zhu XZ: Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists. Br J Pharmacol. 146:604–611. 2005. View Article : Google Scholar : PubMed/NCBI

English BK, Ihle JN, Myracle A and Yi T: Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages. J Exp Med. 178:1017–1022. 1993. View Article : Google Scholar : PubMed/NCBI

Kong X, Liao Y, Zhou L, Zhang Y, Cheng J, Yuan Z and Wang S: Hematopoietic cell kinase (HCK) is essential for NLRP3 inflammasome activation and lipopolysaccharide-induced inflammatory response in vivo. Front Pharmacol. 11:5810112020. View Article : Google Scholar : PubMed/NCBI

Cui W, Sun C, Ma Y, Wang S, Wang X and Zhang Y: Inhibition of TLR4 induces M2 microglial polarization and provides neuroprotection via the NLRP3 inflammasome in Alzheimer's disease. Front Neurosci. 14:4442020. View Article : Google Scholar : PubMed/NCBI

Hua F, Tang H, Wang J, Prunty MC, Hua X, Sayeed I and Stein DG: TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J Cereb Blood Flow Metab. 35:536–542. 2015. View Article : Google Scholar : PubMed/NCBI

Liu Y, Dai Y, Li Q, Chen C, Chen H, Song Y, Hua F and Zhang Z: Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia. Neurosci Lett. 736:1352792020. View Article : Google Scholar : PubMed/NCBI

Poulose SM, Thangthaeng N, Miller MG and Shukitt-Hale B: Effects of pterostilbene and resveratrol on brain and behavior. Neurochem Int. 89:227–233. 2015. View Article : Google Scholar : PubMed/NCBI

Li Q, Chen L, Liu X, Li X, Cao Y, Bai Y and Qi F: Pterostilbene inhibits amyloid-β-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway. J Cell Biochem. 119:7053–7062. 2018. View Article : Google Scholar : PubMed/NCBI

Wang SY, Liu Y, Li XM, Algradi AM, Jiang H, Sun YP, Guan W, Pan J, Kuang HX and Yang BY: Discovery of active ingredients targeted TREM2 by SPR biosensor-UPLC/MS recognition system, and investigating the mechanism of anti-neuroinflammatory activity on the lignin-amides from Datura metel seeds. Molecules. 26:59462021. View Article : Google Scholar : PubMed/NCBI

Liu Y, Yang X, Lei Q, Li Z, Hu J, Wen X, Wang H and Liu Z: PEG-PEI/siROCK2 protects against Aβ42-induced neurotoxicity in primary neuron cells for Alzheimer disease. Cell Mol Neurobiol. 35:841–848. 2015. View Article : Google Scholar : PubMed/NCBI

Liu Y, Zhang H, Peng A, Cai X, Wang Y, Tang K, Wu X, Liang Y, Wang L and Li Z: PEG-PEI/siROCK2 inhibits Aβ42-induced microglial inflammation via NLRP3/caspase 1 pathway. Neuroreport. 33:26–32. 2022. View Article : Google Scholar

Schneider KS, Groß CJ, Dreier RF, Saller BS, Mishra R, Gorka O, Heilig R, Meunier E, Dick MS, Ćiković T, et al: The inflammasome drives GSDMD-independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity. Cell Rep. 21:3846–3859. 2017. View Article : Google Scholar : PubMed/NCBI

Han C, Hu Q, Yu A, Jiao Q and Yang Y: Mafenide derivatives inhibit neuroinflammation in Alzheimer's disease by regulating pyroptosis. J Cell Mol Med. 25:10534–10542. 2021. View Article : Google Scholar : PubMed/NCBI

Wang CZ, Du GJ, Zhen Z, Calway T and Yuan CS: Significant dose differences in donepezil purchased from the United States and Canada. Ann Intern Med. 155:279–280. 2011. View Article : Google Scholar : PubMed/NCBI

Birks JS and Harvey RJ: Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev. 6:CD0011902018.PubMed/NCBI

Wang H, Zong Y, Han Y, Zhao J, Liu H and Liu Y: Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer's disease: A systematic review and meta-analysis. Expert Opin Drug Saf. 21:407–415. 2022. View Article : Google Scholar : PubMed/NCBI

Kim J, Lee HJ, Park SK, Park JH, Jeong HR, Lee S, Lee H, Seol E and Hoe HS: Donepezil regulates LPS and Aβ-stimulated neuroinflammation through MAPK/NLRP3 inflammasome/STAT3 signaling. Int J Mol Sci. 22:106372021. View Article : Google Scholar

Kim HG, Moon M, Choi JG, Park G, Kim AJ, Hur J, Lee KT and Oh MS: Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo. Neurotoxicology. 40:23–32. 2014. View Article : Google Scholar

Chen M, Chen Z, Wang Y, Tan Z, Zhu C, Li Y, Han Z, Chen L, Gao R, Liu L and Chen Q: Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. Autophagy. 12:689–702. 2016. View Article : Google Scholar : PubMed/NCBI

Devi TS, Somayajulu M, Kowluru RA and Singh LP: TXNIP regulates mitophagy in retinal Müller cells under high-glucose conditions: Implications for diabetic retinopathy. Cell Death Dis. 8:e27772017. View Article : Google Scholar

Gao Y, Li J, Li J, Hu C and Zhang L, Yan J, Li L and Zhang L: Tetrahydroxy stilbene glycoside alleviated inflammatory damage by mitophagy via AMPK related PINK1/Parkin signaling pathway. Biochem Pharmacol. 177:1139972020. View Article : Google Scholar : PubMed/NCBI

Li F, Zhang T, He Y, Gu W, Yang X, Zhao R and Yu J: Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE^−/− mice. J Ethnopharmacol. 247:1122322020. View Article : Google Scholar

Mu Y, Xu Z, Zhou X, Zhang H, Yang Q, Zhang Y, Xie Y, Kang J, Li F and Wang S: 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-gluc oside attenuates ischemia/reperfusion-induced brain injury in rats by promoting angiogenesis. Planta Med. 83:676–683. 2017.

Zhou W, Yang Y, Mei C, Dong P, Mu S, Wu H, Zhou Y, Zheng Y, Guo F and Yang JQ: Inhibition of rho-kinase downregulates Th17 cells and ameliorates hepatic fibrosis by schistosoma japonicum infection. Cells. 8:12622019. View Article : Google Scholar : PubMed/NCBI

Kimura T, Horikoshi Y, Kuriyagawa C and Niiyama Y: Rho/ROCK pathway and noncoding RNAs: Implications in ischemic stroke and spinal cord injury. Int J Mol Sci. 22:115732021. View Article : Google Scholar : PubMed/NCBI

Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, Gonzalez-DeWhitt PA, Gelfanova V, Hale JE, May PC, et al: Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science. 302:1215–1217. 2003. View Article : Google Scholar : PubMed/NCBI

Scheiblich H and Bicker G: Regulation of microglial phagocytosis by RhoA/ROCK-inhibiting drugs. Cell Mol Neurobiol. 37:461–473. 2017. View Article : Google Scholar

Alokam R, Singhal S, Srivathsav GS, Garigipati S, Puppala S, Sriram D and Perumal Y: Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including autism spectrum disorder. Mol Biosyst. 11:607–617. 2015. View Article : Google Scholar

Moon MY, Kim HJ, Li Y, Kim JG, Jeon YJ, Won HY, Kim JS, Kwon HY, Choi IG, Ro E, et al: Involvement of small GTPase RhoA in the regulation of superoxide production in BV2 cells in response to fibrillar Aβ peptides. Cell Signal. 25:1861–1869. 2013. View Article : Google Scholar : PubMed/NCBI

Zhang X, Ye P, Wang D, Liu Y, Cao L, Wang Y, Xu Y and Zhu C: Involvement of RhoA/ROCK signaling in Aβ-induced chemotaxis, cytotoxicity and inflammatory response of microglial BV2 cells. Cell Mol Neurobiol. 39:637–650. 2019. View Article : Google Scholar : PubMed/NCBI

van der Meer DLM, Degenhardt T, Väisänen S, de Groot PJ, Heinäniemi M, de Vries SC, Müller M, Carlberg C and Kersten S: Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis. Nucleic Acids Res. 38:2839–2850. 2010. View Article : Google Scholar : PubMed/NCBI

Xia P, Pan Y, Zhang F, Wang N, Wang E, Guo Q and Ye Z: Pioglitazone confers neuroprotection against ischemia-induced pyroptosis due to its inhibitory effects on HMGB-1/RAGE and Rac1/ROS pathway by activating PPAR-ɤ. Cell Physiol Biochem. 45:2351–2368. 2018. View Article : Google Scholar

Janani C and Ranjitha Kumari BD: PPAR gamma gene-a review. Diabetes Metab Syndr. 9:46–50. 2015. View Article : Google Scholar

Stark JM, Coquet JM and Tibbitt CA: The role of PPAR-γ in allergic disease. Curr Allergy Asthma Rep. 21:452021. View Article : Google Scholar

Kumar AP, P P, Kumar BRP, Jeyarani V, Dhanabal SP and Justin A: Glitazones, PPAR-γ and neuroprotection. Mini Rev Med Chem. 21:1457–1464. 2021. View Article : Google Scholar

Furth N, Pateras IS, Rotkopf R, Vlachou V, Rivkin I, Schmitt I, Bakaev D, Gershoni A, Ainbinder E, Leshkowitz D, et al: LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state. Life Sci Alliance. 1:e2018001712018. View Article : Google Scholar : PubMed/NCBI

Villapol S: Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation. Cell Mol Neurobiol. 38:121–132. 2018. View Article : Google Scholar

Moosecker S, Gomes P, Dioli C, Yu S, Sotiropoulos I and Almeida OFX: Activated PPARγ abrogates misprocessing of amyloid precursor protein, tau missorting and synaptotoxicity. Front Cell Neurosci. 13:2392019. View Article : Google Scholar

de la Monte SM and Wands JR: Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis. 9:167–181. 2006. View Article : Google Scholar : PubMed/NCBI

Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, et al: Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: A preliminary study. Am J Geriatr Psychiatry. 13:950–958. 2005.PubMed/NCBI

Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA and Roses AD; Rosiglitazone in Alzheimer's Disease Study Group: Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 6:246–254. 2006. View Article : Google Scholar : PubMed/NCBI

Mandrekar-Colucci S, Karlo JC and Landreth GE: Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci. 32:10117–10128. 2012. View Article : Google Scholar : PubMed/NCBI

Moreno S, Farioli-Vecchioli S and Cerù MP: Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience. 123:131–145. 2004. View Article : Google Scholar

Liu ZJ, Liu W, Liu L, Xiao C, Wang Y and Jiao JS: Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function. Evid Based Complement Alternat Med. 2013:4709752013.PubMed/NCBI

Song GJ, Nam Y, Jo M, Jung M, Koo JY, Cho W, Koh M, Park SB and Suk K: A novel small-molecule agonist of PPAR-γ potentiates an anti-inflammatory M2 glial phenotype. Neuropharmacology. 109:159–169. 2016. View Article : Google Scholar : PubMed/NCBI

Qi Y, Zhang Q and Zhu H: Huang-Lian Jie-Du decoction: A review on phytochemical, pharmacological and pharmacokinetic investigations. Chin Med. 14:572019. View Article : Google Scholar : PubMed/NCBI

Wong LR, Tan EA, Lim MEJ, Shen W, Lian XL, Wang Y, Chen L and Ho PCL: Functional effects of berberine in modulating mitochondrial dysfunction and inflammatory response in the respective amyloidogenic cells and activated microglial cells-in vitro models simulating Alzheimer's disease pathology. Life Sci. 282:1198242012. View Article : Google Scholar

Hagl S, Asseburg H, Heinrich M, Sus N, Blumrich EM, Dringen R, Frank J and Eckert GP: Effects of long-term rice bran extract supplementation on survival, cognition and brain mitochondrial function in aged NMRI mice. Neuromolecular Med. 18:347–363. 2016. View Article : Google Scholar : PubMed/NCBI

El-Din SS, Abd ES, Rashed L, Fayez S, Aboulhoda BE, Heikal OA, Galal AF and Nour ZA: Possible role of rice bran extract in microglial modulation through PPAR-gamma receptors in alzheimer's disease mice model. Metab Brain Dis. 36:1903–1915. 2021. View Article : Google Scholar : PubMed/NCBI

De Felice FG and Ferreira ST: Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes. 63:2262–2272. 2014. View Article : Google Scholar : PubMed/NCBI

Bouriche H, Meziti H, Senator A and Arnhold J: Anti-inflammatory, free radical-scavenging, and metal-chelating activities of Malva parviflora. Pharm Biol. 49:942–946. 2011. View Article : Google Scholar : PubMed/NCBI

Medrano-Jiménez E, Jiménez-Ferrer Carrillo I, Pedraza-Escalona M, Ramírez-Serrano CE, Álvarez-Arellano L, Cortés-Mendoza J, Herrera-Ruiz M, Jiménez-Ferrer E, Zamilpa A, Tortoriello J, et al: Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism. J Neuroinflammation. 16:1432019. View Article : Google Scholar

Villapol S, Yaszemski AK, Logan TT, Sanchez-Lemus E, Saavedra JM and Symes AJ: Candesartan, an angiotensin II AT₁-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacology. 37:2817–2829. 2012. View Article : Google Scholar : PubMed/NCBI

Shindo T, Takasaki K, Uchida K, Onimura R, Kubota K, Uchida N, Irie K, Katsurabayashi S, Mishima K, Nishimura R, et al: Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors. Biol Pharm Bull. 35:2141–2147. 2012. View Article : Google Scholar : PubMed/NCBI

Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE and Wolozin B: Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis. BMJ. 340:b54652010. View Article : Google Scholar : PubMed/NCBI

Wang ZF, Li J, Ma C, Huang C and Li ZQ: Telmisartan ameliorates Aβ oligomer-induced inflammation via PPARγ/PTEN pathway in BV2 microglial cells. Biochem Pharmacol. 171:1136742020. View Article : Google Scholar

He Z, Li X, Han S, Ren B, Hu X, Li N, Du X, Ni J, Yang X and Liu Q: Bis(ethylmaltolato)oxidovanadium (IV) attenuates amyloid-beta-mediated neuroinflammation by inhibiting NF-κB signaling pathway via a PPARγ-dependent mechanism. Metallomics. 13:mfab0362021. View Article : Google Scholar

Yang Z, Liu B, Yang LE and Zhang C: Platycodigenin as potential drug candidate for Alzheimer's disease via modulating microglial polarization and neurite regeneration. Molecules. 24:32072019. View Article : Google Scholar : PubMed/NCBI

Pan D, Xu Y, Zhang L, Su Q, Chen M, Li B, Xiao Q, Gao Q, Peng X, Jiang B, et al: Gene expression profile in peripheral blood mononuclear cells of postpartum depression patients. Sci Rep. 8:101392018. View Article : Google Scholar : PubMed/NCBI

Ahn S, Jang DM, Park SC, An S, Shin J, Han BW and Noh M: Cyclin-dependent kinase 5 inhibitor butyrolactone I elicits a partial agonist activity of peroxisome proliferator-activated receptor γ. Biomolecules. 10:2752020. View Article : Google Scholar

Wang J, Zhu G, Sun C, Xiong K, Yao T, Su Y and Fang H: TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2/STAT3 signaling pathway. Microb Cell Fact. 19:1582020. View Article : Google Scholar : PubMed/NCBI

Kulesza DW, Ramji K, Maleszewska M, Mieczkowski J, Dabrowski M, Chouaib S and Kaminska B: Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells. Lab Invest. 99:1607–1621. 2019. View Article : Google Scholar : PubMed/NCBI

Lee DY, Hwang CJ, Choi JY, Park MH, Song MJ, Oh KW, Han SB, Park WK, Cho HY, Cho SY, et al: KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer's disease models. Oncotarget. 8:68654–68667. 2017. View Article : Google Scholar : PubMed/NCBI

Zhang ZH, Yu LJ, Hui XC, Wu ZZ, Yin KL, Yang H and Xu Y: Hydroxy-safflor yellow A attenuates Aβ_1-42-induced inflammation by modulating the JAK2/STAT3/NF-κB pathway. Brain Res. 1563:72–80. 2014. View Article : Google Scholar : PubMed/NCBI

Zheng ZV, Chen J, Lyu H, Lam S, Lu G, Chan WY and Wong GKC: Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage. Stroke Vasc Neurol. 7:62–70. 2022. View Article : Google Scholar :

Wan J, Fu AK, Ip FC, Ng HK, Hugon J, Page G, Wang JH, Lai KO, Wu Z and Ip NY: Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: Implications in Alzheimer's disease. J Neurosci. 30:6873–6881. 2010. View Article : Google Scholar : PubMed/NCBI

Carret-Rebillat AS, Pace C, Gourmaud S, Ravasi L, Montagne-Stora S, Longueville S, Tible M, Sudol E, Chang RC, Paquet C, et al: Neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation. Sci Rep. 5:84892015. View Article : Google Scholar

Jin P, Kim JA, Choi DY, Lee YJ, Jung HS and Hong JT: Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer's disease mice model. J Neuroinflammation. 10:22013. View Article : Google Scholar : PubMed/NCBI

Choi JY, Hwang CJ, Lee DY, Gu SM, Lee HP, Choi DY, Oh KW, Han SB and Hong JT: (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol ameliorates LPS-mediated memory impairment by inhibition of STAT3 pathway. Neuromolecular Med. 19:555–570. 2017. View Article : Google Scholar : PubMed/NCBI

Hussein G, Sankawa U, Goto H, Matsumoto K and Watanabe H: Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod. 69:443–449. 2006. View Article : Google Scholar : PubMed/NCBI

Han JH, Lee YS, Im JH, Ham YW, Lee HP, Han SB and Hong JT: Astaxanthin ameliorates lipopolysaccharide-induced neuroinflammation, oxidative stress and memory dysfunction through inactivation of the signal transducer and activator of transcription 3 pathway. Mar Drugs. 17:1232019. View Article : Google Scholar : PubMed/NCBI

Safar MM, Shahin NN, Mohamed AF and Abdelkader NF: Suppression of BACE1 and amyloidogenic/RAGE axis by sitagliptin ameliorates PTZ kindling-induced cognitive deficits in rats. Chem Biol Interact. 328:1091442020. View Article : Google Scholar : PubMed/NCBI

Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marié I, Maurin T, Wang L, Figueroa H, Herman M, et al: Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron. 57:680–690. 2008. View Article : Google Scholar : PubMed/NCBI

Millot P, San C, Bennana E, Porte B, Vignal N, Hugon J, Paquet C, Hosten B and Mouton-Liger F: STAT3 inhibition protects against neuroinflammation and BACE1 upregulation induced by systemic inflammation. Immunol Lett. 228:129–134. 2020. View Article : Google Scholar : PubMed/NCBI

Long QH, Wu YG, He LL, Ding L, Tan AH, Shi HY and Wang P: Suan-Zao-Ren decoction ameliorates synaptic plasticity through inhibition of the Aβ deposition and JAK2/STAT3 signaling pathway in AD model of APP/PS1 transgenic mice. Chin Med. 16:142021. View Article : Google Scholar

Jia T, Xing Z, Wang And H and Li G: Protective effect of dexmedetomidine on intestinal mucosal barrier function in rats after cardiopulmonary bypass. Exp Biol Med (Maywood). 247:498–508. 2022. View Article : Google Scholar

Wang LC, Liao LX, Zhao MB, Dong X, Zeng KW and Tu PF: Protosappanin A exerts anti-neuroinflammatory effect by inhibiting JAK2-STAT3 pathway in lipopolysaccharide-induced BV2 microglia. Chin J Nat Med. 15:674–679. 2017.PubMed/NCBI

Porro C, Cianciulli A, Trotta T, Lofrumento DD and Panaro MA: Curcumin regulates anti-inflammatory responses by JAK/STAT/SOCS signaling pathway in BV-2 microglial cells. Biology (Basel). 8:512019.PubMed/NCBI

Amalraj A, Pius A and Gopi S and Gopi S: Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives-a review. J Tradit Complement Med. 7:205–233. 2016. View Article : Google Scholar

He G and Karin M: NF-κB and STAT3-key players in liver inflammation and cancer. Cell Res. 21:159–168. 2011. View Article : Google Scholar

Sim DY, Lee HJ, Jung JH, Im E, Hwang J, Kim DS and Kim SH: Suppression of STAT3 phosphorylation and RelA/p65 acetylation mediated by MicroRNA134 plays a pivotal role in the apoptotic effect of lambertianic acid. Int J Mol Sci. 20:29932019. View Article : Google Scholar : PubMed/NCBI

Song SY, Jung YY, Hwang CJ, Lee HP, Sok CH, Kim JH, Lee SM, Seo HO, Hyun BK, Choi DY, et al: Inhibitory effect of ent-Sauchinone on amyloidogenesis via inhibition of STAT3-mediated NF-κB activation in cultured astrocytes and microglial BV-2 cells. J Neuroinflammation. 11:1182014. View Article : Google Scholar

Kim J, Park JH, Park SK and Hoe HS: Sorafenib modulates the LPS- and Aβ-induced neuroinflammatory response in cells, wild-type mice, and 5xFAD mice. Front Immunol. 12:6843442021. View Article : Google Scholar

Hei YY, Xin M, Zhang H, Xie XX, Mao S and Zhang SQ: Synthesis and antitumor activity evaluation of 4,6-disubstituted quinazoline derivatives as novel PI3K inhibitors. Bioorg Med Chem Lett. 26:4408–4413. 2016. View Article : Google Scholar : PubMed/NCBI

You JS, Li CY, Chen W, Wu XL, Huang LJ, Li RK, Gao F, Zhang MY, Liu HL and Qu WL: A network pharmacology-based study on Alzheimer disease prevention and treatment of Qiong Yu Gao. BioData Min. 13:22020. View Article : Google Scholar : PubMed/NCBI

Yang S, Chen Z, Cao M, Li R, Wang Z and Zhang M: Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation. Mol Med Rep. 15:2588–2594. 2017. View Article : Google Scholar : PubMed/NCBI

Liu X, Wang H, Bei J, Zhao J, Jiang G and Liu X: The protective role of miR-132 targeting HMGA2 through the PI3K/AKT pathway in mice with Alzheimer's disease. Am J Transl Res. 13:4632–4643. 2021.PubMed/NCBI

Hwang SY, Jung JS, Lim SJ, Kim JY, Kim TH, Cho KH and Han IO: LY294002 inhibits interferon-gamma-stimulated inducible nitric oxide synthase expression in BV2 microglial cells. Biochem Biophys Res Commun. 318:691–697. 2004. View Article : Google Scholar : PubMed/NCBI

He Y, Zhou A and Jiang W: Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons. Neural Regen Res. 8:2744–2753. 2013.

Zu HB, Liu XY and Yao K: DHCR24 overexpression modulates microglia polarization and inflammatory response via Akt/GSK3β signaling in Aβ_25-35 treated BV-2 cells. Life Sci. 260:1184702020. View Article : Google Scholar

Sarajärvi T, Haapasalo A, Viswanathan J, Mäkinen P, Laitinen M, Soininen H and Hiltunen M: Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis. J Biol Chem. 284:34433–34443. 2009. View Article : Google Scholar : PubMed/NCBI

Yang W, Liu Y, Xu QQ, Xian YF and Lin ZX: Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K/Akt/GSK-3 β pathway in experimental models of Alzheimer's disease. Oxid Med Cell Longev. 2020:47541952020. View Article : Google Scholar

Ivanovics G and Horvath S: Raphanin, an antibacterial principle of the radish (Raphanus sativus). Nature. 160:2971947. View Article : Google Scholar : PubMed/NCBI

Lonze BE and Ginty DD: Function and regulation of CREB family transcription factors in the nervous system. Neuron. 35:605–623. 2002. View Article : Google Scholar : PubMed/NCBI

Ahn SH, Suh JS, Jang YK, Kim HS, Choi GH, Kim E and Kim TJ: Rhynchosia volubilis promotes cell survival via cAMP-PKA/ERK-CREB pathway. Pharmaceuticals (Basel). 15:732022. View Article : Google Scholar : PubMed/NCBI

Hu YJ, Sun Q, Zhang WH, Huo YJ, Xu CJ and Liu JF: Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation. Acta Pharmacol Sin. 40:460–467. 2019. View Article : Google Scholar :

Viola H, Furman M, Izquierdo LA, Alonso M, Barros DM, de Souza MM, Izquierdo I and Medina JH: Phosphorylated cAMP response element-binding protein as a molecular marker of memory processing in rat hippocampus: effect of novelty. J Neurosci. 20:RC1122000. View Article : Google Scholar : PubMed/NCBI

Dineley KT, Westerman M, Bui D, Bell K, Ashe KH and Sweatt JD: Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci. 21:4125–4133. 2001. View Article : Google Scholar : PubMed/NCBI

Yamamoto-Sasaki M, Ozawa H, Saito T, Rösler M and Riederer P: Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res. 824:300–303. 1999. View Article : Google Scholar : PubMed/NCBI

Mizuno M, Yamada K, Maekawa N, Saito K, Seishima M and Nabeshima T: CREB phosphorylation as a molecular marker of memory processing in the hippocampus for spatial learning. Behav Brain Res. 133:135–141. 2002. View Article : Google Scholar : PubMed/NCBI

Sharma VK and Singh TG: CREB: A multifaceted target for Alzheimer's disease. Curr Alzheimer Res. 17:1280–1293. 2020. View Article : Google Scholar

Li C, Chen T, Zhou H, Feng Y, Hoi MPM, Ma D, Zhao C, Zheng Y and Lee SMY: BHDPC is a novel neuroprotectant that provides anti-neuroinflammatory and neuroprotective effects by inactivating NF-κB and activating PKA/CREB. Front Pharmacol. 9:6142018. View Article : Google Scholar

Ghosh M, Xu Y and Pearse DD: Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. J Neuroinflammation. 13:92016. View Article : Google Scholar : PubMed/NCBI

Tripathi MK, Kartawy M and Amal H: The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders. Redox Biol. 34:1015672020. View Article : Google Scholar : PubMed/NCBI

Zhang J, Guo J, Zhao X, Chen Z, Wang G, Liu A, Wang Q, Zhou W, Xu Y and Wang C: Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice. Behav Brain Res. 250:230–237. 2013. View Article : Google Scholar : PubMed/NCBI

Zeitlin R, Patel S, Burgess S, Arendash GW and Echeverria V: Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Res. 1417:127–136. 2011. View Article : Google Scholar : PubMed/NCBI

Bitner RS, Markosyan S, Nikkel AL and Brioni JD: In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease. Neuropharmacology. 60:460–466. 2011. View Article : Google Scholar

Medhurst AD, Atkins AR, Beresford IJ, Brackenborough K, Briggs MA, Calver AR, Cilia J, Cluderay JE, Crook B, Davis JB, et al: GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther. 321:1032–1045. 2007. View Article : Google Scholar : PubMed/NCBI

Wang J, Liu B, Sun F, Xu Y, Luan H, Yang M, Wang C, Zhang T, Zhou Z and Yan H: Histamine H3R antagonist counteracts the impaired hippocampal neurogenesis in lipopolysaccharide-induced neuroinflammation. Int Immunopharmacol. 110:1090452022. View Article : Google Scholar : PubMed/NCBI

Hiraga N, Adachi N, Liu K, Nagaro T and Arai T: Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains. Eur J Pharmacol. 557:236–244. 2007. View Article : Google Scholar

Amin FU, Shah SA, Badshah H, Khan M and Kim MO: Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ_1-42-induced oxidative stress. J Nanobiotechnology. 15:122017. View Article : Google Scholar

von Otter M, Landgren S, Nilsson S, Zetterberg M, Celojevic D, Bergström P, Minthon L, Bogdanovic N, Andreasen N, Gustafson DR, et al: Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. Mech Ageing Dev. 131:105–110. 2010. View Article : Google Scholar : PubMed/NCBI

Kanninen K, Malm TM, Jyrkkänen HK, Goldsteins G, Keksa-Goldsteine V, Tanila H, Yamamoto M, Ylä-Herttuala S, Levonen AL and Koistinaho J: Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci. 39:302–313. 2008. View Article : Google Scholar

Li XX, Zheng X, Liu Z, Xu Q, Tang H, Feng J, Yang S, Vong CT, Gao H and Wang Y: Cryptotanshinone from Salvia miltiorrhiza Bunge (Danshen) inhibited inflammatory responses via TLR4/MyD88 signaling pathway. Chin Med. 15:202020. View Article : Google Scholar : PubMed/NCBI

Fragoulis A, Siegl S, Fendt M, Jansen S, Soppa U, Brandenburg LO, Pufe T, Weis J and Wruck CJ: Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease. Redox Biol. 12:843–853. 2017. View Article : Google Scholar : PubMed/NCBI

Bilia AR, Scalise L, Bergonzi MC and Vincieri FF: Analysis of kavalactones from Piper methysticum (kava-kava). J Chromatogr B Analyt Technol Biomed Life Sci. 812:203–214. 2004. View Article : Google Scholar : PubMed/NCBI

Mattioli R, Francioso A, d'Erme M, Trovato M, Mancini P, Piacentini L, Casale AM, Wessjohann L, Gazzino R, Costantino P and Mosca L: Anti-inflammatory activity of a polyphenolic extract from Arabidopsis thaliana in in vitro and in vivo models of Alzheimer's disease. Int J Mol Sci. 20:7082019. View Article : Google Scholar : PubMed/NCBI

Rateb ME, Houssen WE, Schumacher M, Harrison WT, Diederich M, Ebel R and Jaspars M: Bioactive diterpene derivatives from the marine sponge Spongionella sp. J Nat Prod. 72:1471–1476. 2009. View Article : Google Scholar : PubMed/NCBI

Alvariño R, Alonso E, Abbasov ME, Chaheine CM, Conner ML, Romo D, Alfonso A and Botana LM: Gracilin A derivatives target early events in Alzheimer's disease: In vitro effects on neuroinflammation and oxidative stress. ACS Chem Neurosci. 10:4102–4111. 2019. View Article : Google Scholar : PubMed/NCBI

Wang X and Asghar M: Protein disulfide isomerase regulates renal AT1 receptor function and blood pressure in rats. Am J Physiol Renal Physiol. 313:F461–F466. 2017. View Article : Google Scholar :

Itoh K, Mimura J and Yamamoto M: Discovery of the negative regulator of Nrf2, Keap1: A historical overview. Antioxid Redox Signal. 13:1665–1678. 2010. View Article : Google Scholar : PubMed/NCBI

Wu H, Zhao G, Jiang K, Li C, Qiu C and Deng G: Engeletin alleviates lipopolysaccharide-induced endometritis in mice by inhibiting TLR4-mediated NF-κB activation. J Agric Food Chem. 64:6171–6178. 2016. View Article : Google Scholar : PubMed/NCBI

Huang Z, Ji H, Shi J, Zhu X and Zhi Z: Engeletin attenuates Aβ1-42-induced oxidative stress and neuroinflammation by Keap1/Nrf2 pathway. Inflammation. 43:1759–1771. 2020. View Article : Google Scholar : PubMed/NCBI

Barone E, Di Domenico F, Sultana R, Coccia R, Mancuso C, Perluigi M and Butterfield DA: Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med. 52:2292–2301. 2012. View Article : Google Scholar : PubMed/NCBI

Zou Y, Hong B, Fan L, Zhou L, Liu Y, Wu Q, Zhang X and Dong M: Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: Involvement of the GSK-3β/Nrf2 signaling pathway. Free Radic Res. 47:55–63. 2013. View Article : Google Scholar

Eom HW, Park SY, Kim YH, Seong SJ, Jin ML, Ryu EY, Kim MJ and Lee SJ: Bambusae caulis in taeniam modulates neuroprotective and anti-neuroinflammatory effects in hippocampal and microglial cells via HO-1- and Nrf-2-mediated pathways. Int J Mol Med. 30:1512–1520. 2012. View Article : Google Scholar : PubMed/NCBI

Chen J, Yin W, Tu Y, Wang S, Yang X, Chen Q, Zhang X, Han Y and Pi R: L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-κB inhibition and Nrf2 pathway activation. Eur J Pharmacol. 806:1–9. 2017. View Article : Google Scholar : PubMed/NCBI

Zhan TW, Tian YX, Wang Q, Wu ZX, Zhang WP, Lu YB and Wu M: Cangrelor alleviates pulmonary fibrosis by inhibiting GPR17-mediated inflammation in mice. Int Immunopharmacol. 62:261–269. 2018. View Article : Google Scholar : PubMed/NCBI

Jin S, Wang X, Xiang X, Wu Y, Hu J, Li Y, Lin DY, Tan Y and Wu X: Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ_1-42 through Nrf2/HO-1 and NF-κB signaling pathway in mice. Int Immunopharmacol. 101:1083352021. View Article : Google Scholar

Gao X, He D, Liu D, Hu G, Zhang Y, Meng T, Su Y, Zhou A, Huang B, Du J and Fu S: Beta-naphthoflavone inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf-2/HO-1-NF-kappaB signaling axis. Immunobiology. 225:1519652020. View Article : Google Scholar

Just PA, Charawi S, Denis RGP, Savall M, Traore M, Foretz M, Bastu S, Magassa S, Senni N, Sohier P, et al: Lkb1 suppresses amino acid-driven gluconeogenesis in the liver. Nat Commun. 11:61272020. View Article : Google Scholar : PubMed/NCBI

Marinangeli C, Didier S, Ahmed T, Caillerez R, Domise M, Laloux C, Bégard S, Carrier S, Colin M, Marchetti P, et al: AMP-activated protein kinase is essential for the maintenance of energy levels during synaptic activation. iScience. 9:1–13. 2018. View Article : Google Scholar : PubMed/NCBI

Vingtdeux V, Davies P, Dickson DW and Marambaud P: AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol. 121:337–349. 2011. View Article : Google Scholar :

Shah SA, Yoon GH, Chung SS, Abid MN, Kim TH, Lee HY and Kim MO: Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits. Mol Psychiatry. 22:407–416. 2017. View Article : Google Scholar :

Vingtdeux V, Chandakkar P, Zhao H, d'Abramo C, Davies P and Marambaud P: Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation. FASEB J. 25:219–231. 2011. View Article : Google Scholar :

Domise M, Didier S, Marinangeli C, Zhao H, Chandakkar P, Buée L, Viollet B, Davies P, Marambaud P and Vingtdeux V: AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. Sci Rep. 6:267582016. View Article : Google Scholar : PubMed/NCBI

Li C, Zhang C, Zhou H, Feng Y, Tang F, Hoi M, He C, Ma D, Zhao C and Lee S: Inhibitory effects of betulinic acid on LPS-induced neuroinflammation involve M2 microglial polarization via CaMKKβ-Dependent AMPK activation. Front Mol Neurosci. 11:982018. View Article : Google Scholar

Voss U and Ekblad E: Lipopolysaccharide-induced loss of cultured rat myenteric neurons-role of AMP-activated protein kinase. PLoS One. 9:e1140442014. View Article : Google Scholar

Zhou Z, Zhang L, Liu Y, Huang C, Xia W, Zhou H, Zhou Z and Zhou X: Luteolin protects chondrocytes from H O oxidative injury and attenuates osteoarthritis progression by 2 2-induced activating AMPK-Nrf2 signaling. Oxid Med Cell Longev. 2022:56357972022. View Article : Google Scholar

Zhou F, Wang M, Ju J, Wang Y, Liu Z, Zhao X, Yan Y, Yan S, Luo X and Fang Y: Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. Am J Transl Res. 11:199–209. 2019.PubMed/NCBI

Park SY, Choi MH, Park G and Choi YW: Petasites japonicus bakkenolide B inhibits lipopolysaccharide-induced pro-inflammatory cytokines via AMPK/Nrf2 induction in microglia. Int J Mol Med. 41:1683–1692. 2018.

Lee KP, Kang S, Park SJ, Choi YW, Lee YG and Im DS: Anti-allergic and anti-inflammatory effects of bakkenolide B isolated from Petasites japonicus leaves. J Ethnopharmacol. 148:890–894. 2013. View Article : Google Scholar : PubMed/NCBI

Li J, Wen PY, Li WW and Zhou J: Upregulation effects of tanshinone IIA on the expressions of NeuN, Nissl body, and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain tissues of rat models of Alzheimer's disease. Neuroreport. 26:758–766. 2015. View Article : Google Scholar : PubMed/NCBI